Breaking news in spinal cord injury research: FDA approved phase I clinical trial of human, autologous schwann cell transplantation in patients with spinal cord injuries

Neural Regen Res. 2012 Aug 5;7(22):1685-7. doi: 10.3969/j.issn.1673-5374.2012.22.001.
No abstract available